LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Organogenesis (NASDAQ: ORGO)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ORGO Organogenesis
Cavorsi Robert / officer: Vice President, Strategy
03/09/2025
Sell
$5.16
210
$1K
189,586
NASDAQ ORGO Organogenesis
Cavorsi Robert / officer: Vice President, Strategy
03/09/2025
Sell
$5.16
61
$315
189,525
NASDAQ ORGO Organogenesis
Driscoll Michael Joseph / director
03/04/2025
Sell
$5.10
25,000
$128K
166,879
NASDAQ ORGO Organogenesis
Cavorsi Robert / officer: Vice President, Strategy
03/01/2025
Sell
$6.21
667
$4K
189,796
NASDAQ ORGO Organogenesis
Cavorsi Robert / officer: Vice President, Strategy
02/19/2025
Buy
$3.53
63,830
$225K
63,830
NASDAQ ORGO Organogenesis
Bilbo Patrick / officer: Chief Operating Officer
02/19/2025
Buy
$3.53
190,475
$672K
190,475
NASDAQ ORGO Organogenesis
Montecalvo Antonio S. / officer: Vice President, Health Policy
02/19/2025
Buy
$3.53
43,956
$155K
43,956
NASDAQ ORGO Organogenesis
Grow Brian / officer: Chief Commercial Officer
02/19/2025
Buy
$3.53
189,369
$668K
189,369
NASDAQ ORGO Organogenesis
Freedman Lori / officer: Chief Admin. and Legal Officer
02/19/2025
Buy
$3.53
167,625
$592K
167,625
NASDAQ ORGO Organogenesis
Francisco David / officer: Chief Financial Officer
02/19/2025
Buy
$3.53
170,841
$603K
170,841
NASDAQ ORGO Organogenesis
Gillheeney Gary S. / director, officer: President and CEO
02/19/2025
Buy
$3.53
732,596
$2.586M
732,596